- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
MediTek parent sees '95 results soar
The corporate parent of imaging services firm MediTek Health postedsharply higher sales and income for its 1995 fiscal year (end-October).Heico of Hollywood, FL, said the good news was due to gains inMediTek's business as well as that of Heico's
The corporate parent of imaging services firm MediTek Health postedsharply higher sales and income for its 1995 fiscal year (end-October).Heico of Hollywood, FL, said the good news was due to gains inMediTek's business as well as that of Heico's aerospace operations.
For the year, Heico enjoyed revenues of $40.4 million, up 25%from $32.4 million in 1994. Net income for 1995 was $2.7 million,up 83% over the $1.5 million registered last year, a figure thatdoes not include an accounting change that increased 1994 netincome by $381,000.
For the fourth quarter of 1995, Heico had revenues of $10.7million and net income of $753,000, compared to revenues of $9million and net income of $532,000 in the same period a year ago.
Heico said MediTek's operating income increased 54% over lastyear, while sales gained 12%.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
